Background Image

Türkiye Vaccine Institute

Phase IIB Trial of TURKOVAC in Adolescents

“Phase IIB Trial of TURKOVAC in Adolescents” has been launched after TURKOVAC, which is the first domestic COVID-19 vaccine developed with the support of TÜSEB, was administered in 81 provinces in Türkiye. 

The volunteers at the age of 16 – 18 with no chronic diseases can participate in the trial. Within the scope of the study, some of the volunteers will be administered TURKOVAC, some of them will be administered CoronaVac

The centres are as follows: 

Paediatric Infectious Diseases Clinic, Ankara City Hospital
Division of Paediatric Infections, Faculty of Medicine, Çukurova University
Department of Paediatrics, Faculty of Medicine, Ege University
Paediatrics Clinic, Adana City Training and Research Hospital, University of Health Sciences
Paediatric Infectious Diseases Clinic, Prof. Dr. Cemil Taşçıoğlu City Hospital 
Division of Paediatric Infectious Diseases, Faculty of Medicine, Ankara University
Dr. Behçet Uz Paediatrics and Surgery Training and Research Hospital, University of Health Sciences, İzmir
Division of Paediatric Infectious Diseases, Erciyes University Medical Faculty Hospitals
Paediatric Infectious Diseases Clinic, Marmara University, İstanbul Pendik Training and Research Hospital
Department of Child Health and Diseases, Hacettepe University Faculty of Medicine
Paediatrics Clinic, University of Health Sciences, İzmir Tepecik Training and Research Hospital
Paediatric Infections Clinic, İstanbul Şişli Hamidiye Etfal Training and Research Hospital
Division of Paediatric Infectious Diseases, İstanbul Faculty of Medicine, İstanbul University 
Division of Paediatric Infectious Diseases, Faculty of Medicine, Eskişehir Osmangazi University